Hibsago Hepatitis B Shot Kept Virus Controlled in Nearly 1 in 5 Off Treatment but Carries Boxed Warning
FDA approved Hibsago for chronic hepatitis B with a boxed warning for liver reactions and low platelets. Here is who qualifies and what to monitor.
Medical Daily ·